SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

Pyng Medical Launches New Sternal IO & Pelvic Stabilization Devices at the EMS Today Tradeshow

FASTResponder Sternal IO & T-PODResponder Pelvic Stabilization Devices Entered in Hot Products Competition

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/14 -- Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care personnel, announces it will launch two new products specifically designed for the emergency medical services market at the EMS Today Tradeshow taking place February 6-8, 2014 at the Walter E. Washington Convention Centre in Washington, DC. The new devices launching are:


--  FASTResponder(TM) Sternal Intraosseous (IO) Device 
--  T-PODResponder(TM) Pelvic Stabilization Device

The EMS Today Tradeshow typically attracts more than 4,200 attendees, including key decision makers in emergency medical services, a key new market for Pyng Medical. Both the FASTResponder and T-PODResponder products were accepted as entries for best new product in the EMS Today Hot Products competition. The winner will be announced following the show. In addition, the FASTResponder product will be featured in the New Product Showcase.

The two new products will enable Pyng to expand beyond the military and combat market, to meet the specific needs and compete in both the civilian pre-hospital and hospital markets. "For years, Pyng has provided sternal intraosseous and pelvic stabilization solutions to military & combat personnel," explains Mark Hodge, President and CEO of Pyng. "We're excited to launch two completely customized and new solutions to meet the specific needs of pre-hospital and hospital personnel."

The new FASTResponder Sternal Intraosseous Device enables emergency care providers to easily establish vascular access when peripheral intravenous access fails. With a lightweight and compact all-in-one design featuring automatic depth control, FASTResponder does not require batteries, drilling or pins, unlike other intraosseous devices. This makes the device as easy to learn and fail-safe as possible, a primary need in the civilian market.

The new T-PODResponder Pelvic Stabilization Device provides the critical ability for a single emergency responder to easily stabilize the pelvic region in the field. The new device is compact and highly portable, and uses a unique pulley system to enable symmetrical and circumferential compression. With no metal used, T-PODResponder does not have to be removed and reapplied for important radiological scans, such as X-Ray, MRI and CT scans.

For more information, visit the Pyng Medical EMS Today web page at go.pyng.com/EMSToday or the company website at www.pyng.com.

About Pyng Medical Corp.

Pyng Medical Corp. engineers and markets award-winning trauma and resuscitation products for front-line critical care personnel world-wide. Pyng's product portfolio includes innovative sternal intraosseous (sternal IO) pelvic stabilization and tourniquet devices specifically designed and customized for both the military and civilian markets. With growing markets in North America, Europe and Asia, Pyng develops user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.

More information about Pyng is available on SEDAR at www.sedar.com under the Company's profile and on its website: www.pyng.com.

Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

Contacts:
Pyng Medical Corp.
George Dorin
Chief Financial Officer
(604) 303-7694 x219
www.pyng.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.